Boryung Pharm (003850) — Capital Reinvestment Ratio
Boryung Pharm (003850) has a Capital Reinvestment Ratio of 0.10x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩48.95 Billion) in capital expenditures (₩4.92 Billion). Check 003850 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Boryung Pharm Capital Reinvestment Ratio (2009–2024)
This chart tracks Boryung Pharm's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see 003850 cash flow metrics.
Annual Capital Reinvestment Ratio for Boryung Pharm (2009–2024)
Year-by-year Capital Reinvestment Ratio for Boryung Pharm from 2009 to 2024. See Boryung Pharm free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.25x | ₩80.56 Billion | ₩20.05 Billion | ▼ -55.0% |
| 2023 | 0.55x | ₩42.22 Billion | ₩23.35 Billion | ▼ -24.1% |
| 2022 | 0.73x | ₩27.81 Billion | ₩20.28 Billion | ▲ +171.9% |
| 2021 | 0.27x | ₩60.17 Billion | ₩16.13 Billion | ▼ -34.3% |
| 2020 | 0.41x | ₩44.74 Billion | ₩18.27 Billion | ▼ -71.4% |
| 2019 | 1.43x | ₩47.00 Billion | ₩67.02 Billion | ▲ +1.2% |
| 2018 | 1.41x | ₩38.91 Billion | ₩54.83 Billion | ▼ -50.8% |
| 2016 | 2.87x | ₩9.36 Billion | ₩26.83 Billion | ▲ +427.9% |
| 2012 | 0.54x | ₩18.38 Billion | ₩9.98 Billion | ▼ -64.8% |
| 2011 | 1.54x | ₩9.19 Billion | ₩14.16 Billion | ▲ +24.9% |
| 2010 | 1.23x | ₩24.12 Billion | ₩29.77 Billion | ▼ -60.7% |
| 2009 | 3.14x | ₩3.59 Billion | ₩11.28 Billion | — |